𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of idiopathic lumbosacral plexopathy with intravenous immunoglobulin

✍ Scribed by William J. Triggs; Michael S. Young; Thomas Eskin; Edward Valenstein


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
24 KB
Volume
20
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

✦ Synopsis


Lumbosacral plexopathy (LSP) produces weakness, reflex changes, and sensory loss which cannot be attributed to individual nerve roots or peripheral nerves. The differential diagnosis for LSP includes tumors, trauma, arterial injections, hemorrhage, infection, hereditary susceptibility to pressure palsies, diabetes, vasculitis, and idiopathic LSP. 5 Idiopathic LSP is heralded by pain, followed by weakness, atrophy, and variable sensory loss. 5,6,13 Recovery occurs over months to years, but may be incomplete. 1 Bradley and colleagues described treatment of LSP with corticosteroids 2 and intravenous immunoglobulin (IVIg). 16 We describe treatment of 5 patients with idiopathic LSP with IVIg.


πŸ“œ SIMILAR VOLUMES


Treatment of Lambert-Eaton syndrome with
✍ Mark M. Rich; James W. Teener; Shawn J. Bird πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 165 KB πŸ‘ 2 views

## MUSCLE & NERVE May 1997 improvement is so minimal that it is difficult to detect S: Effect of intravenous immunoglobulin in Lambert-Eaton electrophysiologically. Evaluation of jitter and neuromyasthenic syndrome with small-cell lung cancer: correlation muscular block through single-fiber electr

Successful treatment of orbital myositis
✍ Sarangerel Shambal; Alfred Lindner; Stephan Zierz πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 177 KB πŸ‘ 1 views

By four cycles (7 months) of chemotherapy, strength and reflexes had returned to normal. Neurologic and ophthalmologic evaluations remain normal 16 months after the initial symptoms. Discussion. This patient is remarkable because she had the association of PPNV and optic neuropathy, and because bot

Treatment of chronic inflammatory demyel
✍ Dr. David R. Cornblath; Vinay Chaudhry; John W. Griffin πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 305 KB πŸ‘ 2 views

## Abstract Chronic inflammatory demyelinating polyneuropathy is an immune‐mediated demyelinating peripheral neuropathy usually treated with immunosuppressants. We reviewed our experience treating 15 patients (9 men, 6 women) with intravenous immunoglobulin. Six patients were on other therapies at

Oral high-dose methylprednisolone and in
✍ Altintop, Levent; Albayrak, Davut πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 14 KB πŸ‘ 2 views

Ten adult patient of chronic idiopathic thrombocytopenic purpura (CITP) used oral prednisone and were treated with seven doses of oral high-dose methylprednisolone (30 mg/kg). Nine of ten patients responded after HDMP treatment (plt > 150 Γ— 10 9 /L). Two patients having 8 and 10 years of history ach

Treatment of platelet alloimmunization w
✍ Dr. Shu-Huey Chen; Der-Cherng Liang; Marie Lin πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 221 KB πŸ‘ 2 views

A %year-old girl with severe refractory aplastic anemia had become refractory to platelet transfusion due to platelet alloimmunization. As a result, a huge right parieto-temporooccipital cerebral hematoma and a subarachnoid hemorrhage subsequently occurred. Intravenous immunoglobulin (IVIG) (Green C